-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LEEmL5snihAg84mxI5SkE6DcwJZonwK6sSlGTpL4DKxH73uZTU3r5FyAcwQmOtFn MoHtd0VN5FgpP2PloxZsEw== 0001140361-07-016384.txt : 20070814 0001140361-07-016384.hdr.sgml : 20070814 20070814162905 ACCESSION NUMBER: 0001140361-07-016384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070810 FILED AS OF DATE: 20070814 DATE AS OF CHANGE: 20070814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J CENTRAL INDEX KEY: 0001068029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 071055678 BUSINESS ADDRESS: STREET 1: C/O DISCOVERY LABORATORIES INC STREET 2: 3359 DURHAM ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVE STREET 2: #701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER NAME: FORMER CONFORMED NAME: SCHABER CHRISTOPHER DATE OF NAME CHANGE: 19980811 4 1 doc1.xml FORM 4 X0202 4 2007-08-10 0 0000812796 DOR BIOPHARMA INC DORB 0001068029 SCHABER CHRISTOPHER J 1101 BRICKELL AVENUE SUITE 701-S MIAMI FL 33131 1 1 0 0 Chief Executive Officer Stock Options (right ot buy) 0.27 2007-08-10 4 A 0 500000 0 A 2007-08-10 2016-08-28 Common Stock 500000 500000 D Stock Options (Right to Buy) 0.47 2007-08-10 4 A 0 900000 0 A 2007-08-10 2017-08-09 Common Stock 900000 900000 D 500,000 stock options were granted on August 10, 2007 as a result of the amendment to the original 2,500,000 options granted on August 29, 2006. This amendment was required because under the 2005 Equity Incentive Plan only 2,000,000 stock options were authorized in a calendar year. This amendment was filed on August 14, 2007 as a Form 3/A (Amendment) of the originally filed Form 3 of September 1, 2006. These stock options will vest 33.3% initially and 8.325% of the remaining balance will vest quarterly over a three year period. The stock options were granted at an exercise price of $0.47 per share, which is a 68% premium to the Company?s common stock price of $0.28 on August 10, 2007. The stock options, which are for a term of 10 years from the date of grant and subject to earlier termination upon the occurrence of certain events related to termination of employment, vest at the rate of 25% immediately and 25% per year for 3 years. /s/ Christopher J. Schaber 2007-08-14 -----END PRIVACY-ENHANCED MESSAGE-----